Clinical Trials on Implantable Cardioverter-Defibrillators in Ireland

Total 5 results

Forest Laboratories

Terminated

Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillator (ICD) (SHIELD-2) (SHIELD-2)

Heart Diseases | Cardiovascular Diseases | Arrhythmias, Cardiac | Implantable Cardioverter Defibrillator

United States, Belgium, Canada, Czech Republic, Denmark, France, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden
Medtronic Cardiac Rhythm and Heart Failure
Medtronic

Completed

PREPARE - Primary Prevention Parameters Evaluation

Syncope | Tachycardia, Ventricular | Implantable Cardioverter Defibrillator (ICD) | Fibrillation, Ventricular

United States, Puerto Rico
Boston Scientific Corporation

Completed

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic (PREEMPT-HF)

Heart Failure | Cardiovascular Disease | Heart Disease | Defibrillators, Implantable | Cardiac Resynchronization Therapy | Monitoring, Physiologic

United States, Spain, United Kingdom, Netherlands, Hong Kong, Denmark, France, Ireland, Australia, Belgium, Canada, Germany, Italy
TYRX, Inc.

Completed

TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD (Centurion)

Cardiac Implantable Electronic Device Infection

United States
MedtronicNeuro

Completed

Implantable Systems Performance Registry (ISPR)

Deep Brain Stimulation | Spinal Cord Stimulation | Sacral Neuromodulation | Drug Infusion (Implantable Pumps)

United States, France, Spain, Germany, United Kingdom, Italy, Austria

Clinical Trials on Implantable Cardioverter-Defibrillators in Ireland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations